oncodaily

Prostate Cancer Radiotherapy: HYPO-RT-PC Study Reveals Significant Gaps Between Patient and Clinician Symptom Reporting

HYPO-RT-PC Study Reveals Significant Gaps Between Patient and Clinician Symptom Reporting / Bowel Toxicity, clinical research ...
BIOENGINEER

Home Transfusions Prove Safe and Feasible for Hospice Blood Cancer Patients

A prospective pilot study shows that symptom-guided home blood transfusions for hospice patients with hematologic ...

Malignant Lymphoma (ML) -- Is the effectiveness of CAR-T related to the youth of the cells?

When CAR-T is recommended, when is the best time to collect cells?When the treatment known as CAR-T is recommended, the first ...
FT Markets

Karyopharm to Present Selinexor Data in Patients with Myelofibrosis and Multiple Myeloma at the 68th American Society of Hematology Annual Meeting and Exposition (ASH)

Karyopharm Therapeutics Inc. (Nasdaq: KPTI) ("Karyopharm" or the "Company"), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that abstracts from two of its ...
BIOENGINEER

Diabetes and pre-treatment fatigue flag men at risk of years-long exhaustion after prostate radiotherapy

An international study of 1758 men with non-metastatic prostate cancer found that pre-radiotherapy fatigue and diabetes were ...
oncodaily

Tarlatamab-Associated Neurotoxicity in SCLC: New Study Identifies TIAN in Patients With Brain Metastases

A real-world SCLC study identifies suspected TIAN in 17% of tarlatamab-treated patients, highlighting neurological risks in ...
Mena FN

EGFR Inhibitors-Induced Skin Disorders Market And Pipeline Appear Robust With Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight

(MENAFN- GetNews) The EGFR Inhibitors-Induced Skin Disorders market analysis report delivers important insights into ongoing research on pipeline EGFR Inhibitors-Induced Skin Disorders drugs, clinical ...